文献速递烧伤创面修复

右美托咪定与咪达唑仑预给药对烧伤患者氯胺酮-芬太尼镇静镇痛效果的随机对照研究

A study comparing the effect of premedication with intravenous midazolam or dexmedetomidine on ketamine-fentanyl sedoanalgesia in burn patients: A randomized clinical trial.
PubMed 文献 · Burns · 2020-06-03

该随机对照研究比较了静脉右美托咪定与咪达唑仑预给药对烧伤换药/清创时氯胺酮-芬太尼镇静镇痛的影响。右美托咪定组在镇静3、5、10分钟时HR和MAP显著低于基线,咪达唑仑组SpO2下降更明显;两组BIS和RSS无显著组间差异。结论认为两药安全有效,但右美托咪定引起血流动力学改变,咪达唑仑引起呼吸抑制。

要点

  • 右美托咪定组镇静3、5、10分钟时HR和MAP显著低于基线(p<0.05)。
  • 两组镇静10分钟时SpO2均显著下降,咪达唑仑组降幅更大(p<0.05)。
  • 两组BIS和RSS在各时间点无显著组间差异(p>0.05)。

核心结论

  • 右美托咪定引起血流动力学改变,咪达唑仑引起呼吸抑制,但两药用于烧伤疼痛性操作前镇静均安全有效。

研究设计与样本

  • 随机对照研究,纳入烧伤面积15-63%、年龄18-70岁、ASA I-II级并接受疼痛性烧伤护理操作的患者。
  • 患者随机接受静脉右美托咪定1 mcg/kg(组1)或咪达唑仑0.03 mg/kg(组2)预给药。

主要发现

  • 右美托咪定组镇静3、5、10分钟时HR和MAP显著低于基线(p<0.05)。
  • 两组镇静10分钟时SpO2均显著下降,咪达唑仑组降幅更大(p<0.05)。
  • 两组BIS在镇静10分钟及操作15、60分钟时显著降低(p<0.05),但组间无显著差异(p>0.05)。
  • 两组RSS在镇静3、5、10分钟时高于基线(p<0.05),组间无显著差异(p>0.05);操作15分钟时RSS显著高于0分钟值,45和60分钟时显著降低(p<0.05)。

临床怎么用

  • 烧伤换药/清创前可选择右美托咪定或咪达唑仑预给药辅助氯胺酮-芬太尼镇静,需分别关注血流动力学和呼吸抑制风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Dressing changes and wound care-debridement procedures often cause fear and anxiety in burn patients, as these processes are quite painful. In order to determine the best method for alleviating pain during these procedures, the current study compared the efficacy and safety of intravenous dexmedetomidine and midazolam for premedication prior to these painful burn care procedures. METHODS: This comparative and randomized study included patients who had a burn size of 1563%, were aged 1870 years, were diagnosed with the American Society of Anesthesiologists physical status (ASA I-II), and who underwent painful burn care procedures. Patients were intravenously administered either 1 mcg/kg dexmedetomidine (Group 1) or 0.03 mg/kg midazolam (Group 2) prior to the burn care procedure. Recorded at predetermined time points for each patient were heart rhythm (HR), mean arterial pressure (MAP), peripheral oxygen saturation (SpO2), standard bispectral index (BIS), and Ramsay Sedation Scale (RSS). RESULTS: In the dexmedetomidine group, HR and MAP measurements of patients at the 3rd, 5th, and 10th mins during sedation were significantly lower than the baseline values (p < 0.05). A significant decrease in SpO2 was observed in both groups at the 10th min during sedation, but the decline was higher in the midazolam group (p < 0.05). BIS measurements of the patients in both groups were significantly lower at 10 min. during sedation and at 15th and 60th mins during the procedure (p < 0.05). However, there was no significant difference between the group (p > 0.05). The RSS scales of both groups in during the sedation were higher in the 3rd, 5th and 10th mins than the baseline values (p < 0.05), but there was no significant difference between the groups (p > 0.05). The RSS scales of groups in during the burn procedure were significantly higher at 15 th min than the 0 th values, while the RSS scales of both groups were significantly lower in the 45th and 60th mins (p < 0.05). CONCLUSION: Results of this study indicate that dexmedetomidine causes hemodynamic alterations while midazolam causes respiratory depression. However, these effects are not severe, and we conclude that both agents are safe and effective to ensure sedation prior to painful burn-care procedures.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Gencer M, Sezen O. A study comparing the effect of premedication with intravenous midazolam or dexmedetomidine on ketamine-fentanyl sedoanalgesia in burn patients: A randomized clinical trial. Burns. 2020. PMID: 33277091. doi:10.1016/j.burns.2020.05.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。